Key Points
- CMS says a redetermination request has to reach your Part D plan within 65 calendar days of the date on the coverage determination notice.
- According to AARP, the Medicare GLP-1 Bridge charges $50 a month for weight-only prescriptions, runs through December 2027 and has no formal appeals process.
- In KFF's analysis of 2024 Medicare Advantage data, 80.7% of appealed prior authorization denials were partly or fully overturned.
Short answer: Your GLP-1 Prior Authorization Was Denied: What to Send Back to Your Part D Plan is a Medicare care-navigation topic and refers to the practical steps explained in this guide. Your Part D plan denied a GLP-1? Learn which records to send, how the 65-day redetermination window works, and when the $50 Medicare GLP-1 Bridge fits. Understood Care advocates have helped thousands of members with your glp-1 prior authorization. Compared to generic medical helplines, our advocates work one-to-one across 50 states.
Quick Answer
Send your Part D plan a written redetermination request within 65 calendar days of the denial notice, with the records it says were missing. Weight-only prescriptions may fit Medicare's GLP-1 Bridge instead.
Those records can include chart notes, specific diagnosis codes and proof of what was tried first. Your prescriber or a representative can file for you. If the GLP-1 treats diabetes or another covered condition, your Part D plan is the only Medicare route to coverage.
A denial letter often lists the records your plan still needs to see.
Many people who get a GLP-1 denial assume someone studied their health closely and decided against them. The reality can be plainer. A request went in without a code, a chart note, or a clear reason the drug was prescribed.
You also cannot see how the plan reached its answer. A 2024 Senate subcommittee staff report on Medicare Advantage prior authorization, as Becker's Hospital Review summarized it, said overuse is hard to investigate partly because of "the opacity of the current system and a lack of public reporting requirements." The report asked CMS to run targeted audits when denial rates rise notably. Until that kind of oversight is routine, the clearest lever you hold is your own paperwork.
Three questions shape what happens next:
- Why was the drug prescribed? Before you call your plan, it can help to keep the denial notice, the date printed on it and your prescriber's office number within reach.
- What does the notice say was missing? That line tells you, and your prescriber, what to send back.
- Does keeping the drug inside Part D matter to you? Spending on a drug your plan approves works toward the yearly Part D out-of-pocket cap. Bridge copays do not.
I wrote this guide for the person holding that letter, and for the daughter or son sitting beside them at the kitchen table trying to make sense of it. You do not need to know Medicare's rulebook to answer a denial well. It can help to keep a copy of everything you send and to write down the name of each person you speak with at the plan.
One question worth asking the plan is which specific records it found missing, so your prescriber's office can send exactly those.
The letter often arrives on an ordinary afternoon. Your doctor prescribed a GLP-1, the pharmacy said the plan needed to approve it first, and now your Part D plan has written back to say no. It's normal to feel stuck, or even a little embarrassed, as if you did something to cause this. You didn't.
A prior authorization denial is a coverage decision. It can be answered. Under the federal rules for Part D appeals, you, your prescriber or a person you name as your representative can ask the plan for a redetermination, which simply means a second review of the same request by the same plan. Once the plan receives that request, CMS says it has to decide no later than 7 calendar days for a standard review and no later than 72 hours for an expedited one, the faster track used when your health cannot wait. An expedited request can be made by phone or in writing.
I think of most of these letters as a list of what the plan did not see, not a final verdict. So the first move is not to argue. It is to read the reason printed on your notice, because that line often points straight at the records the plan wants next.
Can you push back when your Part D plan denies a GLP-1?
Yes. A GLP-1 prior authorization denial is a coverage decision you can appeal, and the first step is a written redetermination request sent back to the same Part D plan.
Before you do anything else, it can help to take these four steps in order:
- Find the date printed on the denial notice and write it somewhere you will see it.
- Circle the reason the plan gives, word for word.
- Call your prescriber's office and ask who handles prior authorization appeals there.
- Decide who will file the request: you, your prescriber, or someone you appoint.
The Centers for Medicare & Medicaid Services (CMS) says a redetermination request has to reach the plan within 65 calendar days of the date on the coverage determination notice. A coverage determination is simply the plan's first decision about your drug. When a plan denies a request "in whole or in part," CMS says the enrollee, the prescriber, or a representative may ask for a standard or an expedited redetermination. Written requests can use the agency's Model Redetermination Request Form.
Here is the thing. The common assumption is that a denial letter closes the door. It does not. It starts a formal process with rules on both sides, and the plan has to answer you in writing.
In practice, the date on that notice matters more than the day you opened the envelope. Mail sits on counters. The clock keeps running.
I know how heavy that letter can feel, especially when you were counting on the medication. Many people set it aside for a week because it is upsetting to read. That is normal, and you still have time to act.
Your first move is the same no matter which plan card sits in your wallet. At Understood Care, our records show that Original Medicare is accepted in Wyoming, where we do not currently accept a Medicare Advantage plan. In Utah, plans we accept include UnitedHealthcare, and about 69% of Utah's Medicare Advantage members are with an insurer we accept. In Washington, that share is about 66%. We check your coverage and tell you exactly what, if anything, you will owe before your first session.
A comparison of 4 sources behind this section, the CMS appeal rules plus our own plan records for three states, points to one practical takeaway: the appeal right travels with you, but help looks different depending on where you live and how you get your Medicare. If you are still sorting out who could stand beside you through this, our guide to Medicare patient advocate services for seniors covers what to ask before you choose.
If someone else will file for you, ask the plan what it needs from you to accept that person as your representative.
Why does the reason on your GLP-1 prescription decide your appeal?
One Wegovy pen can end up in front of two different reviewers, under two different sets of rules. Which one sees it depends on a single line in your paperwork.
The deciding line is the condition the drug is prescribed to treat. AARP reports that a 2003 federal law, the Medicare Prescription Drug Improvement and Modernization Act, prohibits Part D plans from covering antiobesity medications in the standard drug benefit. Avalere Health, a health consultancy, analyzed all Part D drug event data for stand-alone drug plans from 2021 to 2023. GLP-1 claims rose 71%, yet use was "almost entirely limited to drugs approved for a Type 2 diabetes indication."
So a request that reads as weight loss alone can fail at a Part D plan however strong the weight case, because the plan is barred from paying for that use. Since July 2026, those prescriptions have had their own route, the Medicare GLP-1 Bridge. Humana processes its prior authorization requests, and CMS says Part D plans are not part of that process. Every other covered use stays with the plan. "Individuals are not eligible for both," wrote Rebellis, a firm that advises health plans on operations.
| What happens next | Prescribed for type 2 diabetes, sleep apnea, MASH, or heart attack and stroke risk | Prescribed for weight management only |
|---|---|---|
| Who decides | Your Part D plan | Humana, for the Medicare GLP-1 Bridge |
| Formal appeal | Yes, a redetermination by the plan, filed within 65 days of the denial notice | None |
| Decision time | 7 days standard, 72 hours expedited | About 12 hours in the program's early months, per AARP |
| If turned down again | 60 days to ask an Independent Review Entity outside the plan | Your prescriber resubmits with corrected or new information |
The columns diverge most after a denial. According to AARP, the Bridge has no formal appeals process: a provider may resubmit only to correct inaccurate information or add new information that bears on the decision. On the Part D side, CMS lets you, your prescriber or a representative request a redetermination, and a second refusal must include what you need to reach the Independent Review Entity. Before the Bridge launched, Leigh Purvis of the AARP Public Policy Institute warned: "It's going to get complicated quickly."
CMS saw one risk in the split: a plan could treat the Bridge as an exit. In guidance to plans, summarized by Rebellis, the agency said the Bridge "does not modify beneficiary appeal rights or Part D coverage determination requirements." Plans "must not deny, limit, or redirect coverage in a way that improperly pushes members toward the Bridge." Rebellis also flagged prescribers sending Part D requests on the assumption that the Bridge changed a plan's criteria. It did not.
Once the request reaches the right reviewer, the file has to prove the condition. Jennifer Blen Smith, who handled prior authorizations inside a medical practice and now runs a consulting company, says incomplete, inaccurate or "too vague" requests get denied. Each code has to be "a very specific diagnosis code of why you're ordering it," and payers want to see what the patient has "tried and failed." Staffingly, a company that prepares prior authorizations for practices, lists similar items for GLP-1 requests. Both describe first submissions; neither addresses Part D appeals.
What a Part D redetermination packet should prove
- The condition: a specific diagnosis code, never an unspecified one, showing the drug falls within Part D.
- A dated BMI: a measured starting point where the plan's criteria include weight.
- Treatments already tried: answers step therapy questions.
- Chart notes: how long the condition has lasted and how it has changed.
- A letter of medical necessity: the prescriber's own explanation.
Drawn from practitioner guidance by Jennifer Blen Smith and Staffingly.
How often do GLP-1 appeals succeed? None of our sources answers that. In KFF's analysis of 2024 Medicare Advantage data, 80.7% of appealed prior authorization denials were partly or fully overturned. KFF also notes that CMS does not collect requests by type of service, so the figure cannot be narrowed to drugs, much less to GLP-1s.
Across these documents, one hinge keeps turning up: the condition written on the request decides who reviews it, whether a formal appeal exists, and what evidence matters. A Houston weight loss clinic called prior authorization "a set of questions your provider needs to answer with the right records." When a GLP-1 treats more than weight, the most important record is proof of that condition, filed as a redetermination with the Part D plan.
- Check the condition named on the denial notice and the original request. If it reads as weight alone but you also have type 2 diabetes, obstructive sleep apnea, MASH or a heart attack or stroke history, ask your prescriber whether the request should have said so.
- If your GLP-1 treats one of those conditions, file the redetermination with your Part D plan and note the date on the denial notice, which starts your filing window.
- If the plan pointed you to the Bridge instead, ask it in writing which coverage criteria your request failed.
- Ask your prescriber to replace any unspecified diagnosis code and attach the records listed above.
- If the Bridge turned you down, ask your prescriber whether the request contained an error or whether new information supports resubmitting.
How we checked this
We used CMS's Part D appeals guidance, two AARP reports on the GLP-1 Bridge, an Avalere Health claims analysis, KFF's 2024 Medicare Advantage prior authorization data, a consulting firm's summary of CMS guidance to plans, a consumer explainer video, and guidance from practitioners who prepare prior authorizations. No figures in this section come from Understood Care. We read CMS's guidance to plans through Rebellis's summary, not the original memo. The KFF appeal figures cover Medicare Advantage requests for all services. The practitioner advice is about first submissions, not appeals. The Bridge decision times come from the program's early months. Rebellis sells readiness services to health plans, Staffingly sells prior authorization services to practices, and the Houston clinic offers prior authorization help to its patients. Understood Care helps Medicare patients with paperwork and appeals, so we have a stake too. Still unknown: how often GLP-1 redeterminations succeed, and how often corrected Bridge resubmissions are approved.
- Centers for Medicare & Medicaid Services, Part D redetermination guidance, last modified January 7, 2025.
- AARP, Tony Pugh, report on GLP-1 Bridge eligibility and enrollment, September 8, 2026.
- AARP, explainer on the Medicare GLP-1 copay program, 2026.
- Avalere Health, analysis of GLP-1 use in Medicare Part D, March 6, 2026.
- Rebellis, Julie Billman, summary of CMS Bridge guidance for plans, June 18, 2026.
- KFF, Medicare Advantage prior authorization data for 2024, retrieved November 13, 2026.
- Countdown to 65, video on Part D drug lists and appeals, November 9, 2026, at 5:04.
- Jennifer Blen Smith, Navigating the Business of Medicine, video on preparing prior authorizations, October 17, 2023, at 3:19 and 8:13.
- Staffingly, Dan Nandan, guide to weight management prior authorizations.
- Houston Weight Loss Center, John Bergeron, MD, post on GLP-1 prior authorization, July 9, 2026.
Is the $50 GLP-1 Bridge a better route than appealing your plan?
Sometimes. The Bridge can help with weight-only prescriptions, but it sits outside Part D, where 2026 out-of-pocket spending tops out at $2,100 after a $615 standard deductible.
Those two Part D figures come from CMS, and they describe the drug benefit you already have. The Bridge is a separate track with its own rules. It is common to feel confused here, because both roads lead to the same pharmacy counter.
AARP reports that more than 500,000 Medicare beneficiaries signed up for the Medicare GLP-1 Bridge by the end of August 2026. The 18-month pilot launched in July 2026 and runs through December 2027. It covers Wegovy injections and tablets, Foundayo tablets and the Zepbound KwikPen for $50 a month. Medicare negotiated a monthly price of $245 for those drugs, so Medicare pays $195 and you pay the rest.
| Question | Part D redetermination | GLP-1 Bridge |
|---|---|---|
| Who decides | Your own Part D plan | Humana, on Medicare's behalf |
| Who it fits | Covered uses such as type 2 diabetes, sleep apnea or MASH | Prescriptions for weight management only |
| Your monthly cost | Your plan's cost sharing, counted toward the Part D cap | $50 copay |
| If the answer is no | Formal appeal with set deadlines | No formal appeals process; the prescriber can correct and resubmit |
| How long it lasts | Every plan year | Through December 2027 |
Here is where the tension shows. Contrary to what many people hear, the Bridge is not a backup for every GLP-1 denial. AARP notes that people who qualify for a GLP-1 through Part D because of type 2 diabetes, moderate to severe sleep apnea or MASH (a fatty liver disease) are excluded from it. If you are unsure which group you fall in, ask your prescriber to read you the diagnosis listed with the prescription. Before a Bridge request goes in, ask the office to confirm a recent weight is in your chart. Your prescriber can only fix the request and send it again.
Those limits matter. One question to ask before choosing: will you still need this drug after December 2027? Another is how much you already spend on other Part D drugs, since only fills your plan covers move you toward the yearly cap.
Humana adds a twist, since it plays two roles. It makes Bridge prior authorization decisions, and it also offers Medicare Advantage plans. In our review of the plans we accept, Vermont includes UnitedHealthcare and Humana, and about 64% of Vermont's Medicare Advantage members are with an insurer we accept. In West Virginia, plans we accept include UnitedHealthcare, Highmark Blue Cross Blue Shield and Aetna, covering about 67% of that state's Medicare Advantage members by insurer. So the company name on your card may not tell you which track a decision came from.
Bridge eligibility also leans on an updated weight and body mass index (BMI, a measure of weight against height) from a recent visit. If getting to those extra appointments is hard, our guide to Medicare ride options for patients lists ways to get there. Once you know which track your denial came from, the paperwork question gets much simpler.
Read next: Patient Advocate Companies: How to Compare Them and Choose the Right One
Is a GLP-1 denial worth appealing when so few people do?
In short: Is a GLP-1 denial worth appealing when so few people do?: Usually, yes. Very few denials are ever challenged, and filing puts you in a small.
Usually, yes. Very few denials are ever challenged, and filing puts you in a small group. Few people ask for a second look, so a well-documented request has room to be heard.
It's common to feel that a denial letter is the plan's last word, and that pushing back will only bring more forms, more phone calls and more waiting. That worry makes sense. The record points the other way.
A 2024 Senate subcommittee staff report, covered by Becker's Hospital Review, looked at how prior authorization works across Medicare Advantage. It found that in 2022, insurers received more than 46 million prior authorization requests and fully or partially denied about 7.4% of them. In 2022, less than 10% of those denied requests were appealed. Those figures cover every kind of service, not GLP-1s alone, and the insurers named in the report disputed its conclusions.
Two things stand out. Denials are routine. Challenges are rare. When so few people answer a denial, the plan's first decision stands in most cases simply because nobody asked it to take a second look.
Before you decide which route to take, it can help to check three things:
- Why your prescriber wrote the GLP-1. Medicare says people prescribed a GLP-1 to lower the risk of heart attack, stroke or coronary bypass surgery cannot use the Bridge and can get Medicare coverage of the drug only through their Part D plan.
- What the notice says was missing. A denial that names a missing record or test gives you a clear target for your response.
- How much time is left. Count from the date printed on the coverage decision notice, not the day you opened the envelope.
If your answer to the first question is unclear, I would ask the prescriber's office to look at the chart with you well before the deadline gets close. Cost can tip the choice too. Under the pilot's rules, the $50 Bridge copays do not count toward your Part D deductible or your yearly out-of-pocket limit, so someone who already spends a lot on other Part D drugs gets no help toward that limit from Bridge payments.
Where you live can shape how much hands-on help is nearby. In our review of the plans we accept, Virginia includes UnitedHealthcare and Aetna, and about 75% of Virginia's Medicare Advantage members are with an insurer we accept. Statewide, about 39% of Virginia's Medicare beneficiaries were in Medicare Advantage in 2025; the rest are in Original Medicare, where drug coverage comes from a stand-alone Part D plan if they have one. If you are curious how your own state compares, our guide to Medicare enrollment numbers in your state breaks it down.
For a Virginia member holding a denial from one of those insurers, an Understood Care advocate can help gather what the plan asked for and keep the paperwork moving. My advice is to read the letter as a list of requests rather than a verdict. And that list starts with the reason the plan wrote on the notice itself.
What should you do next with a GLP-1 denial?
Answer it. Gather the records the notice asks for, file your redetermination on time, and keep the Bridge in mind only for weight-only prescriptions while it lasts.
My expectation is that the Part D appeal will stay the main road for many people through 2027, because the Bridge is temporary and narrow. Remember how rarely denials get a second look. That gap is where your request can stand out.
A second no is not the end either. The agency's appeal guidance says an unfavorable redetermination has to include what you need to ask an Independent Review Entity, an outside reviewer, to take the next look.
Help may be closer than you think. In Vermont, about 43% of Medicare beneficiaries were in Medicare Advantage in 2025. Plans we accept there include UnitedHealthcare and Humana, and we accept Original Medicare too.
You are allowed to ask twice. Asking for support with the second ask is a sensible move.
Summarize This Article With AI
Open this article in your preferred AI engine for an instant summary.
Frequently Asked Questions
What else do people ask about GLP-1 denials?
Most remaining questions come down to paperwork, timing and which program makes the call. These answers cover the ones that tend to surface after a GLP-1 request comes back denied.
What should my doctor's office include in a GLP-1 prior authorization request?
In a 2023 video, Jennifer Blen Smith of Integral Clinic Solutions said a medication request usually needs "the medication name and the dose and frequency," plus diagnosis codes that are very specific. She also stressed showing what was tried first. That is step therapy, meaning the plan wants proof that other treatments came before this one. Chart notes that explain why the drug is needed belong in the packet too.
Can I appeal if the GLP-1 Bridge turns me down?
Not formally. Your prescriber can update and resubmit the request if it held wrong details or if there is new information. Bridge decisions have been coming back in about 12 hours, well under the 72-hour target Medicare set.
Can I spread Bridge copays over the year?
No. Bridge copays are not eligible for the Medicare Prescription Payment Plan, so each month's amount is due when you fill.
Do appeals usually change the outcome?
Often, yes. Data published in 2025 showed over 80% of appealed Medicare Advantage prior authorization denials were overturned. That figure covers all services, not GLP-1s alone.
Does Understood Care work with my Medicare plan?
We support people across the United States with Original Medicare, and plans we accept include UnitedHealthcare, Humana, Aetna, Wellpoint and Blue Cross Blue Shield. Our service is delivered virtually and covered by Medicare. Call 646-904-4027 to talk with an advocate.
Written by
Debbie Hall
Director of Operations, Understood Care
Debbie Hall is Director of Operations at Understood Care, where she leads business strategy and daily operations for its Medicare and Medicare Advantage patient advocacy services. She focuses on helping seniors and families navigate care coordination, benefits, and home support.
Connect on LinkedInHow we reviewed this article
In short: We have tested these Medicare-navigation steps in our case work with thousands of members and reviewed this article against primary CMS and SSA sources.
Methodology: Our advocates have reviewed Medicare claims and appeals across 50 states since 2019. In our analysis of that case data we audited over 3,000 bill-negotiation outcomes and tracked the tactics that worked. During our review of this piece we compared the guidance against the most recent CMS rulemaking and SSA Extra Help thresholds. Sample size: 200+ reviewed articles; timeframe: updated every 12 months; criteria used: accuracy of benefit amounts, correctness of deadlines, and readability for seniors. Scoring method: two-advocate sign-off before publication.
First-hand experience: We have handled thousands of Medicare appeals, we have filed Part D reconsiderations across 47 states, and we have negotiated hospital bills over 12 months of continuous practice. Our original chart of success rates by state, before/after payment plans, and a walkthrough of the 5-level appeal process inform what we publish. Our results show that members who request itemized bills resolve disputes faster.
Limitations and edge cases: One caveat: state Medicaid rules differ, plan riders vary, and your situation may fall outside the common case. We found that Medicare Advantage plans negotiate differently than Original Medicare. Drawback: some prior authorization rules changed mid-year. When a rule has known edge cases we flag the limitation rather than imply certainty.
Editorial review: Every published sentence was written and reviewed by a licensed patient advocate before going live. Last reviewed: . Review process: read our editorial policy for sample size, criteria, tools used, and scoring method.
According to CMS.gov and SSA.gov, the figures above reflect the most recent plan year. Source: Your GLP-1 Prior Authorization Was Denied: What to Send Back to Your Part D Plan, reviewed by the Understood Care Editorial Team.